期刊文献+

执行缺陷综合征的行为学评价测试在帕金森病执行功能研究中的应用及相关因素分析 被引量:7

BADS in study of executive dysfunction in patients with Parkinson's disease: Application and analysis of relevant factors
下载PDF
导出
摘要 目的执行缺陷综合征的行为学评价测试(behavioral assessment of dysexecutive syndrome,BADS)作为一种执行功能障碍的评估量表先前被用于多种疾病的执行功能测试,然而在非痴呆帕金森病(parkinson's disease,PD)中的数据仍然缺乏。文中旨在通过该量表了解PD患者的执行功能障碍及其影响因素。方法应用BADS对68位PD患者和60位健康对照者进行执行功能指标的测试,并收集相关人员的基线资料。结果 BADS评分系统发现PD患者6项子测试和BADS总分评分明显低于对照者[(5.46±3.71)vs(17.78±2.47),P<0.01],而logistic回归分析也发现PD、UPDRSⅢ得分与性别为执行功能障碍的相关因素。结论 PD患者存在日常生活的执行功能障碍,这种障碍主要与疾病本身、性别及病情的严重程度相关。 Objective The behavioral assessment of dysexecutive syndrome (BADS) is a neuropsychological battery for measuring a wide range of executive impairments. However, data on its validity in Parkinson's disease (PD) without dementia are still lacking. The aim of this study was to analyze the executive dysfunction of PD patients and its influencing factors. Methods We con- ducted BADS for 68 PD patients and 60 healthy controls, and analyzed the relevant baseline data of the subjects. Results BADS findings showed that the individual scores and total scores of the PD patients were significantly lower than those of the healthy controls ( [ 5.46 ± 3.71 ] vs [ 17.78 ± 2.47 ], P 〈 0. O1 ). The results of binary stepwise logistic regression procedures revealed that PD, gen der and UPDRS m scores of were associated with executive dysfunction. Conclusion PD patients have problems with the executive function in daily life, which are mainly correlated with the severity of the condition and the gender of the patients.
作者 于路
出处 《医学研究生学报》 CAS 北大核心 2014年第1期63-66,共4页 Journal of Medical Postgraduates
关键词 执行功能 帕金森病 执行功能障碍综合征的行为学评估 Executive dysfunction Parkinson's disease Behavioral assessment of dysexecutive syndrome
  • 相关文献

参考文献17

  • 1Koerts J,Tucha L,Leenders KL. Subjective and objective assessment of executive functions in parkinson' s disease[J].{H}Journal of the Neurological Sciences,2011,(1-2):172-175.
  • 2Muslimovic D,Post B,Speelman JD. Cognitive profile of patients with newly diagnosed Parkinsondesease[J].{H}NEUROLOGY,2005,(8):1239-1245.
  • 3Williams-Gray CH,Evans JR,Goris A. The distinct cognitive syndromes of parkinson's disease:5 year follow-up of the CamPaIGN cohort[J].{H}BRAIN,2009,(11):2958-2969.
  • 4Perfetti B,Varanese S,Mercuri E. Behavioural assessment of dysexecutive syndrome in parkinson's disease without dementia:A comparison with other clinical executive tasks[J].{H}Parkinsonism & Related Disorders,2010,(1):46-50.
  • 5吴江;贾建平;崔丽英.神经病学[M]北京:人民卫生出版社,2010264-265.
  • 6Wilson BA,Alderman N,Burgess PW. Behavioural Assessment of the Dysexecutive Syndrome (BADS)[J].J Occup Psychol Employm Disabil,2003,(2):33-37.
  • 7闫荟如,李红娟,杨新玲.新疆维吾尔族和汉族帕金森病LRRK2基因S1647T多态性研究[J].医学研究生学报,2012,25(7):729-733. 被引量:6
  • 8郭玉霞,杨波,石磊,顾军,陈虹.姜黄素对中脑定位注射脂多糖引起帕金森样病变小鼠的抗炎机制研究[J].医学研究生学报,2012,25(6):582-587. 被引量:10
  • 9Wilson BA,Evans JJ,Emslie H. The development of an ecologically valid test for assessing patients with a dysexecutive syndrome[J].{H}NEUROPSYCHOLOGICAL REHABILITATION,1998,(3):213-228.
  • 10Klepac N,Trkulja V,Relja M. Is quality of life in nondemented Parkinson's disease patients felated to cognitive performance? A clinic-based cross-sectional study[J].{H}European Journal of Neurology,2008.128-133.

二级参考文献23

  • 1Parkinson J. An essay on the shaking palsy[J]. J Neuropsychia- try Clin Neurosci ,2002,14(2) :223-236.
  • 2Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for thera-peutic intervention[J]. Neurobiol Dis, 2010,37 ( 3 ) : 510- 518.
  • 3Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? [ J ] Lancet Neurol, 2009,8 (4) : 382-397.
  • 4Hirsch EC, Vyas S, Hunot S. Neuroinflammation in Parkinsons disease[J]. Parkinsonism Relat Disord, 2012,18 (Suppl 1 ): S210-212.
  • 5Takeuchi H, Jin S, Wang J, et al. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner [J]. J Biol Chem, 2006,281 (30) :21362-21368.
  • 6Waetzig V, Czeloth K, Hidding U, et al. C-Jun N-terminal kina- ses(JNKs) mediate pro-inflamatory actions of microglia[J]. Gli- a, 2005,50(3) :235-246.
  • 7Pan XD, Chen XC, Zhu YG, et al. Neuroprotective role of trip- chlorolide on inflammatory neurotoxicity induced by lipopolysac- charide-activated microglia [ J ]. Biochem Pharmacol, 2008,76 (3) :362-372.
  • 8Hen'era A J, Castafio A, Venero JL, et al. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. [J]. Neurobi- ol Dis, 2000,7(4) :429-447.
  • 9Zhang F, Shi JS, Zhou H, et al. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflarmnatory actions [ J ]. Mol Pharmacol, 2010,78 (3) : 466-477.
  • 10Arafijo CC, Leon LL. Biological activities of Curcuma longa L [J]. Mem Inst Oswaldo Cruz, 2001,96(5) :723-728.

共引文献13

同被引文献39

  • 1吴长鸿,刘斌.第四届全国脑血管病学术会议[J].中华医学信息导报,1996,0(6):4-4. 被引量:137
  • 2王素娟,郝习君,陈长香,马素慧,李淑杏,赵宁.脑梗死患者执行功能障碍的康复策略实施效果[J].中国老年学杂志,2015,35(2):465-467. 被引量:4
  • 3Wang J, Song N, Xu HM, et al. The Role of Iron and Alpha-sy- nuclein Interacting in Parkinson's Disease[ J]. Sheng Li Ke Xue Jin Zhan, 2015, 46(3) : 180-184.
  • 4Jeong SY. David S. Glycosylphosphatidylinositol-anchored ceru- loplasmin is required for iron efflux from cells in the central nerv- ous system[ J]. J Biol Chem, 2003, 278 (29) : 27144-27148.
  • 5Muhlenhoff U, Hoffmann B, Richter N, et al. Compartmentaliza-tion of iron between mitochondria and the cytosol and its regula- tion[J]. Eur J Cell Biol, 2015, 94(7-9) : 292-308.
  • 6Sipe JC, Lee P, Beutler E. Brain iron metabolism and neurode- generative disorders[ J]. Dev Neurosei, 2002, 24 (2-3) : 188- 196.
  • 7Graham JM, Paley MN, Grtinewald RA, et al. Brain iron depo- sition in Parkinson's disease imaged using the PRIME magnetic resonance sequence [ J ]. Brain, 2000, 123 ( Ptl 2) : 2423-2431.
  • 8Filomeni G, Bolafios JP, Mastroberardino PG. Mastroberardino. Redox status and bioenergeties liaison in cancer and neurodegen- eration[J]. Int J Cell Biol, 2012, 2012: 659645.
  • 9Tristan C, Shahani N, Sedlak TW, et al. The diverse functions of GAPDH : views from different subcellular compartments [ J ]. Cell Signal, 2011,23(2) : 317-323.
  • 10Tisdale EJ. Glyceraldehyde-3-phosphate dehydrogenase is required for vesicular transport in the early secretory pathway [ J ]. J Biol Chem, 2001,276(4) : 2480-2486.

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部